The use of cannabinoids in chronic pain.
BMJ Case Rep. 2013 Jul 26;2013.
Abstract
We
present the case of a 56-year-old man who developed chronic pain
following the excision of a facial cancer that was poorly controlled
despite multiple analgesic medications.
Following the starting of nabilone (a synthetic cannabinoid) his pain control was greatly improved and this had a huge impact on his quality of life.
We also managed to significantly reduce his doses of opioid analgesia and ketamine.
We review the current literature regarding the medicinal use of cannabinoids, with an emphasis on chronic pain, in an attempt to clarify their role and how to select patients who may benefit from this treatment.
Following the starting of nabilone (a synthetic cannabinoid) his pain control was greatly improved and this had a huge impact on his quality of life.
We also managed to significantly reduce his doses of opioid analgesia and ketamine.
We review the current literature regarding the medicinal use of cannabinoids, with an emphasis on chronic pain, in an attempt to clarify their role and how to select patients who may benefit from this treatment.
No comments:
Post a Comment